Glaukos’ iPrime Viscodelivery System Gets FDA’s 510(k) Clearance

San Clemente, Calif.-based Glaukos has received the FDA’s 510(k) clearance for its iPrime viscodelivery system for use in ophthalmic surgery.

iPrime is a sterile, single-use, minimally invasive product designed to deliver viscoelastic fluid during eye surgeries.

A pioneer in minimally invasive glaucoma surgery, Glaukos specializes in novel therapies to treat glaucoma, corneal disorders and retinal diseases.